Definitive Healthcare Corp. (NASDAQ:DH) Receives $4.28 Consensus Target Price from Brokerages

Definitive Healthcare Corp. (NASDAQ:DH) has earned a consensus recommendation of “Reduce” from the seven research firms that are covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $4.28.

A number of brokerages recently weighed in on DH. Stifel Nicolaus increased their price objective on shares of Definitive Healthcare from $5.00 to $6.00 and gave the company a “buy” rating in a research report on Friday, August 8th. Robert W. Baird set a $4.00 price target on shares of Definitive Healthcare in a research report on Friday, August 8th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Definitive Healthcare in a research report on Wednesday, October 8th.

Definitive Healthcare Price Performance

Shares of Definitive Healthcare stock opened at $2.97 on Friday. The company has a market cap of $425.13 million, a price-to-earnings ratio of -1.12 and a beta of 1.65. The company’s 50 day moving average is $3.67 and its 200 day moving average is $3.56. Definitive Healthcare has a twelve month low of $2.15 and a twelve month high of $5.68. The company has a quick ratio of 1.65, a current ratio of 1.65 and a debt-to-equity ratio of 0.39.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the business. Goldman Sachs Group Inc. raised its position in Definitive Healthcare by 564.2% in the first quarter. Goldman Sachs Group Inc. now owns 8,716,725 shares of the company’s stock worth $25,191,000 after acquiring an additional 7,404,363 shares during the period. Palisade Capital Management LP increased its stake in shares of Definitive Healthcare by 1.3% in the first quarter. Palisade Capital Management LP now owns 2,265,198 shares of the company’s stock worth $6,546,000 after purchasing an additional 29,774 shares in the last quarter. Arrowstreet Capital Limited Partnership purchased a new stake in shares of Definitive Healthcare in the second quarter worth $4,247,000. Whetstone Capital Advisors LLC purchased a new stake in shares of Definitive Healthcare in the first quarter worth $2,512,000. Finally, Bank of America Corp DE increased its stake in shares of Definitive Healthcare by 23.7% in the second quarter. Bank of America Corp DE now owns 769,397 shares of the company’s stock worth $3,001,000 after purchasing an additional 147,599 shares in the last quarter. 98.67% of the stock is currently owned by institutional investors.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.